@article{2f1e1628816d47b893e69bd11d1bfed4,
title = "Results of a phase 2 trial of selinexor, an oral selective inhibitor of nuclear export (SINE) in 114 patients with gynaecological cancers",
keywords = "Oncology",
author = "Ignace Vergote and B. Lund and H. Havsteen and Z Ujmajuridze and {Van Nieuwenhuysen}, Els and C. Haslund and T. Juhler-Nottrup and Patrick Neven and M. Mau-Sorensen and P. Berteloot and Kranich, {Anne L} and T Rashal and J. Meade and Yosef Landesman and Jean-Richard Saint-Martin and George Wright and M. Crochiere and S Shacham and M Kauffman and Mirza, {M. R.}",
note = "ISI Document Delivery No.: EK4QS Times Cited: 0 Cited Reference Count: 0 Vergote, I. Lund, B. Havsteen, H. Ujmajuridze, Z. Van Nieuwenhuysen, E. Haslund, C. Juhler-Nottrup, T. Neven, P. Mau-Sorensen, M. Berteloot, P. Kranich, A. Rashal, T. Meade, J. Landesman, Y. Saint-Martin, J-R. Wright, G. Crochiere, M. Shacham, S. Kauffman, M. Mirza, M. Raza Karyopharm Therapeutics 0 Oxford univ press Oxford 1569-8041 6; 41st ESMO Congress ; Conference date: 07-10-2016 Through 11-10-2016",
year = "2016",
doi = "10.1093/annonc/mdw374.01",
language = "English",
volume = "27",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "Suppl. 6",
url = "http://www.esmo.org/Conferences/Past-Conferences/ESMO-2016-Congress",
}